Law360 (August 4, 2020, 4:26 PM EDT) -- Citing "good progress" in settlement talks, Bayer AG said it has set aside nearly $1.5 billion to resolve thousands of cases brought by women alleging the company's Essure birth control device was defective and caused injuries, as well as other litigation matters.
The pharmaceutical giant made the announcement in a Monday press release about its second-quarter earnings, saying it had allocated €1.25 billion ($1.47 billion) for potential settlements over Essure and additional litigation. About 27,000 Essure suits are pending in California state court alone, and there are additional cases in other courts across the country.
"Discussions on potential settlements in connection...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!